Intuitive Surgical, Inc.’s financial performance beat analysts’ expectations for the second quarter of 2020, driven by an intra-quarter recovery of system placements as well as procedure volume as the COVID-19 pandemic rages on.
But for Wells Fargo’s analyst Larry Biegelsen, the most important announcement during the call was the launch of the “Extended Use Program,” under which Intuitive will start selling higher-priced surgical instruments that can be used more